Associations among plasma, MRI, and amyloid PET biomarkers of Alzheimer's disease and related dementias and the impact of health‐related comorbidities in a community‐dwelling cohort
Alzheimer's & Dementia · 2024
DOI: 10.1002/alz.13835 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2024. Verfasst von Marc D Rudolph und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Biomarkers, Alzheimer Disease, Magnetic Resonance Imaging. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NIA NIH HHS, Michael J Fox Foundation.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION We evaluated associations between plasma and neuroimaging‐derived biomarkers of Alzheimer's disease and related dementias and the impact of health‐related comorbidities. METHODS We examined plasma biomarkers (neurofilament light chain, glial fibrillary acidic protein, amyloid beta [Aβ] 42/40, phosphorylated tau 181) and neuroimaging measures of amyloid deposition (Aβ‐positron emission tomography [PET]), total brain volume, white matter hyperintensity volume, diffusion‐weighted fractional anisotropy, and neurite orientation dispersion and density imaging free water. Participants were adjudicated as cognitively unimpaired (CU; N = 299), mild cognitive impairment (MCI; N = 192), or dementia (DEM; N = 65). Biomarkers were compared across groups stratified by diagnosis, sex, race, and APOE ε4 carrier status. General linear models examined plasma‐imaging associations before and after adjusting for demographics (age, sex, race, education), APOE ε4 status, medications, diagnosis, and other factors (estimated glomerular filtration rate [eGFR], body mass index [BMI]). RESULTS Plasma biomarkers differed across diagnostic groups (DEM > MCI > CU), were altered in Aβ‐PET‐positive individuals, and were associated with poorer brain health and kidney function. DISCUSSION eGFR and BMI did not substantially impact associations between plasma and neuroimaging biomarkers. Highlights Plasma biomarkers differ across diagnostic groups (DEM > MCI > CU) and are altered in Aβ‐PET‐positive individuals. Altered plasma biomarker levels are associated with poorer brain health and kidney function. Plasma and neuroimaging biomarker associations are largely independent of comorbidities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
- Department Of Neurology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
ORCID-Profile: Marc D Rudolph
Förderung
- NIH HHS
- NIA NIH HHS
- Michael J Fox Foundation
- National Institutes of Health
Zitieren
APA
Rudolph, M. D., Sutphen, C. L., Register, T. C., Whitlow, C. T., Solingapuram Sai, K. K., Hughes, T. M., Bateman, J. R., Dage, J. L., Russ, K. A., Mielke, M. M., Craft, S., & Lockhart, S. N. (2024). Associations among plasma, MRI, and amyloid PET biomarkers of Alzheimer's disease and related dementias and the impact of health‐related comorbidities in a community‐dwelling cohort. Alzheimer's & Dementia. https://doi.org/10.1002/alz.13835
Vancouver
Rudolph MD, Sutphen CL, Register TC, Whitlow CT, Solingapuram Sai KK, Hughes TM, et al. Associations among plasma, MRI, and amyloid PET biomarkers of Alzheimer's disease and related dementias and the impact of health‐related comorbidities in a community‐dwelling cohort. Alzheimer's & Dementia. 2024. doi:10.1002/alz.13835
BibTeX
@article{Rudolph2024,
author = {Rudolph, Marc D and Sutphen, Courtney L and Register, Thomas C and Whitlow, Christopher T and Solingapuram Sai, Kiran K and Hughes, Timothy M and Bateman, James R and Dage, Jeffrey L and Russ, Kristen A and Mielke, Michelle M and Craft, Suzanne and Lockhart, Samuel N},
title = {Associations among plasma, MRI, and amyloid PET biomarkers of Alzheimer's disease and related dementias and the impact of health‐related comorbidities in a community‐dwelling cohort},
journal = {Alzheimer's & Dementia},
year = {2024},
doi = {10.1002/alz.13835}
}
EUVIMED